FDA Approved: NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE — Supplemental Application (Alvogen Inc.)

View source ↗

Summary

FDA approves a supplemental application for nitrofurantoin monohydrate/macrocrystalline submitted by Alvogen Inc., providing regulatory action on this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystitis
• Urinary Tract Infection

Drugs mentioned

• Nitrofurantoin monohydrate/macrocrystalline (Nitrofurantoin monohydrate/macrocrystalline)

Snippet

SUPPL AP for NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE (NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE)